Driving reinvestment in R&D for antibiotics and advocating their responsible use

News

Review on AMR Releases Final Recommendations

  The United Kingdom's Review on Antimicrobial Resistance, chaired by Lord Jim O'Neill, has released its final report: "Tackling Drug-Resistant Infections Globally: final report and recommendations". This report outlines the Review’s final recommendations. It first discusses the mounting problem of resistance and why action is needed to combat it and then provides an overview of the solutions that the Review thinks should be implemented to curtail unnecessary use and increase the supply of new antimicrobials. It then looks at the role of public awareness campaigns, the need to improve sanitation and hygiene, reduce pollution from agriculture and the environment, improve global surveillance,...
Read more

Pew Charitable Trusts Releases Scientific Roadmap for Antibiotic Discovery

The Pew Charitable Trusts released a Scientific Roadmap for Antibiotic Discovery today. The last time scientists discovered a truly new antibiotic that made it to market was in 1984. This report outlines what needs to be done to end this dangerous drought in antibiotic discovery, and why we desperately need to discover new antibiotics that can defeat increasingly resistant superbugs. Click here to read the report.

For more information, please visit Pew’s antibiotic resistance project.

...
Read more

DRIVE-AB Conference 2016: Stimulating innovation, sustainable use and global access to antibiotics

Stimulating innovation, sustainable use and global access to antibiotics

2 June 2016 Amsterdam, The Netherlands The consortium is organizing a high-level conference to bring together policy makers, regulatory and public health experts, and economists to identify and evaluate reward models that are feasible, practical and can be implemented globally. This conference is supported by the EU Presidency of the Netherlands. This event is expected to stimulate a dialogue among international decision-makers on the implementation of R&D incentive policies which will help to inform DRIVE-AB final recommendations, which will be announced in 2017. Aim of the Conference DRIVE-AB will present the preliminary results of its research...
Read more

BEAM Alliance is DRIVE-AB’s newest Associate Partner

The European Beam Alliance is DRIVE-AB's newest Associate Partner. The group of small and medium sized European biopharmaceutical companies are involved in innovation in the field of antimicrobial resistance research and work to improve the regulatory, investment, and commercial environments in Europe for research, development, approval and market viability of new products combating antimicrobial resistance. The Beam Alliance will support DRIVE-AB in our work to develop new reward models to drive investment in antibiotic discovery and development activities.  ...
Read more

IDSA Releases New Antibiotic Stewardship Guidelines with Focus on Practical Advice for Implementation

The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) have developed and published new guidelines on antibiotic stewardship in the journal Clinical Infectious Diseases. Preauthorization of broad-spectrum antibiotics and prospective review after two or three days of treatment should form the cornerstone of antibiotic stewardship programs to ensure the right drug is prescribed at the right time for the right diagnosis. These are among the numerous recommendations included in new guidelines released by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) and published...
Read more